Found 7 matching trials
Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma
PHASE1This is a Phase I Study to Evaluate the Safety, Tolerability, and Efficacy ...
Location
Institut Català D'Oncologia
Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer
PHASE2A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine...
Location
Hoag Memorial Hospital Presbyterian
Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors
PHASE1The purpose of this study is to determine the safety and tolerability of VC...
Location
Hospital Vall d'Hebron
A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer
PHASE1The purpose of this study is to determine the safety and tolerability of th...
Location
Institut Català d'Oncologia
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
PHASE1This is a single-center phase 1 study to evaluate the safety and feasibilit...
Status
Active Not Recruiting
Location
University of Pennsylvania
Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma
NAPhase I study, single site, open label with dose escalation, for evaluate s...
Location
Hospital Sant Joan de Déu
A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer
PHASE1The goal of this clinical trial is to learn if the new administration regim...
Location
Hospital 12 de Octubre